4SCAR-CD44v6 T Cell Therapy Targeting Cancer

NCT04427449 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Cancers Which Are CD44v6 Positive

Interventions

BIOLOGICAL: CD44v6-specific CAR gene-engineered T cells

Sponsor

Shenzhen Geno-Immune Medical Institute

Collaborators

[object Object]
[object Object]
[object Object]